CHINA FAW GROUP CO., LTD. (short for FAW), formerly named China First Automobile Works, can trace its roots back to 1953.

吉利德近年来在医药领域的征程可谓波折不断，尤其是在其重点布局的抗肿瘤领域，遭遇了一系列挫折。尽管在长效HIV疗法上仍保持着一定的竞争力，但在抗肿瘤药物的研发上，吉利德似乎陷入了越努力越不见成效的困境。

In August 2023, XPENG announced that it would issue A-class ordinary shares accounting for 3.25% of its total ...